Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuropharmacological Mechanisms of Self-Dissolution
NCT03736980Completed
- Sponsor
- University of Zurich
- Start
- Oct 2013
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of psilocybin (4 arms), sponsored by University of Zurich. Primary endpoints: fMRI resting state activity (BOLD signal) at 60 minutes and EEG measurement (ERPs) at 60 minutes. Started Oct 2013; status: completed.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT03736980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03736980.